DACH Pharmacy E-commerce Market: Data and Trends Towards 2025

The digital transformation of the DACH pharmacy sector continues to reshape consumer access to pharmaceutical and health products. Data from recent market analyses indicates a sustained expansion of online pharmacy channels, driven by evolving digital infrastructure and shifting purchasing patterns across Germany, Austria, and Switzerland. This report examines key market metrics and trends projected for 2025.

Market Volume and Growth Trajectories in DACH

The DACH region’s online pharmacy market demonstrates consistent growth, solidifying its position as a significant segment within the broader healthcare retail landscape. Projections for 2025 indicate a continued upward trajectory, building upon the expansion observed in preceding years.

In 2023, the combined online pharmacy market volume for Germany, Austria, and Switzerland reached an estimated €5.2 billion. This figure encompasses sales of over-the-counter (OTC) medications, health and wellness products, and a growing share of prescription (Rx) medications, particularly in Germany following the introduction of the e-Rezept. By the close of 2024, the market is estimated to expand to approximately €5.8 billion, representing a year-on-year growth rate of around 11.5%.

Looking towards 2025, market analysts project the DACH online pharmacy sector to reach a total volume of approximately €6.5 billion. This forecast implies a compound annual growth rate (CAGR) of 11.9% from 2023 to 2025. The German market remains the primary driver, accounting for over 70% of the regional volume. Austria and Switzerland also contribute to this growth, albeit from smaller bases.

The following table provides an overview of the projected market values and growth for the DACH online pharmacy sector:

Note: CHF values for Switzerland are presented to reflect local currency reporting, with an approximate conversion rate of 1 EUR = 0.96 CHF for comparison.

Within Germany, the introduction and increasing adoption of the e-Rezept are key accelerators for the Rx segment’s digitalization. While OTC products historically dominated online sales, the digital prescription has begun to shift this dynamic. In Austria, regulatory frameworks permit a broader range of OTC products online, while in Switzerland, the market is characterized by a mix of online pharmacies and direct-to-consumer health retailers.

Leading Market Participants and Competitive Dynamics

The DACH online pharmacy market is characterized by a high degree of concentration among a few dominant players, particularly in Germany. These entities have established extensive logistical networks and brand recognition.

As of early 2024, Redcare Pharmacy N.V. (formerly Shop Apotheke Europe) maintains the largest market share in the DACH region. Its German operations, under the Shop Apotheke brand, reported gross merchandise value (GMV) of €1.84 billion for 2023 across its core markets, with a significant portion attributed to the DACH region. The company’s market share in Germany’s online pharmacy sector is estimated to be approximately 40-45% for OTC and health products.

DocMorris (Zur Rose Group AG), another major player, holds the second-largest market share. In 2023, DocMorris reported an increase in active customers to 3.7 million in Germany and Austria. Their focus on the e-Rezept in Germany positions them to capture a substantial share of the digital prescription market. DocMorris’s market share in the German online pharmacy segment (OTC and Rx) is estimated at 25-30%.

Other notable participants include apo.com healthcare GmbH and various smaller regional online pharmacies and aggregators. The competitive landscape is also influenced by traditional brick-and-mortar pharmacy chains that have launched or expanded their online offerings. However, their combined online market share remains significantly lower than the pure-play online pharmacies.

Market concentration is evident: the top two players collectively account for over 65% of the total online pharmacy sales volume in Germany. This dynamic suggests that new entrants face considerable barriers to market penetration, primarily due to established brand loyalty, extensive product assortments, and robust supply chain infrastructures of the incumbents.

Product Category Performance and Consumer Demand Shifts

The composition of products sold through DACH online pharmacies is evolving, influenced by regulatory changes and consumer preferences. Historically, OTC medications and health & wellness products constituted the vast majority of online sales.

Over-the-Counter (OTC) Medications and Health & Wellness Products: These categories continue to form the backbone of online pharmacy sales. In 2023, OTC drugs represented approximately 55% of total online pharmacy revenue in Germany, with health & wellness products (e.g., dietary supplements, medical devices, personal care items) contributing another 30-35%. Growth in these segments is driven by convenience, competitive pricing, and wider product selection compared to traditional pharmacies. Projections for 2025 indicate sustained growth rates of 8-10% annually for these categories online.

Prescription (Rx) Medications: The most significant shift in product category performance is observed in the Rx segment, particularly in Germany. The nationwide rollout and increasing adoption of the e-Rezept (electronic prescription) are critical drivers. While the initial adoption rates were moderate, by early 2024, approximately 1.5-2 million e-Rezept prescriptions were being redeemed weekly through online pharmacies and digital services. This represents a substantial increase from previous years and is projected to accelerate significantly through 2025.

The share of Rx medications in the total online pharmacy market in Germany is expected to grow from an estimated 5-7% in 2023 to 12-15% by the end of 2025. This growth is contingent on continued physician adoption of e-Rezept issuance and patient comfort with digital redemption pathways. In Austria and Switzerland, the online sale of Rx medications remains more restricted, with specific regulations limiting their availability to certain online channels or requiring complex verification processes.

Cosmetics and Beauty Products: While not core pharmaceutical products, many online pharmacies have expanded into adjacent categories. Cosmetics and beauty products, often dermatologically tested or specifically marketed for sensitive skin, represent a growing segment. This category typically accounts for 5-10% of online pharmacy sales and is projected to maintain a steady growth rate, leveraging existing customer trust in pharmacy brands.

Consumer Adoption and Engagement Metrics

Consumer behavior in the DACH region indicates a growing propensity for purchasing pharmacy products online, driven by factors such as convenience, price transparency, and broader product availability.

Online Penetration Rates: In Germany, the percentage of the adult population that has purchased pharmacy products online at least once in the past 12 months reached approximately 35% in 2023, up from 30% in 2021. This penetration rate is projected to exceed 40% by 2025. Austria and Switzerland exhibit slightly lower, but similarly growing, adoption rates, estimated at 28% and 25% respectively for 2023.

Purchase Frequency and Average Order Value (AOV): Data suggests that repeat purchases are common, particularly for chronic conditions or routine health & wellness items. The average purchase frequency for active online pharmacy users in Germany is estimated at 3-4 times per year. The AOV for online pharmacy orders in Germany ranges from €45 to €60, with Rx orders tending to have a higher value due to the nature of the medications. In Switzerland, the AOV can be higher, partly due to generally higher healthcare costs and product pricing.

Demographics: While online pharmacy usage spans all age groups, the 35-54 age bracket constitutes the largest segment of online pharmacy customers, representing approximately 40% of users. However, significant growth is observed among the 55+ demographic, driven by increasing digital literacy and the convenience of home delivery for individuals with mobility challenges or those seeking to avoid physical pharmacy visits.

Payment Methods: Preferred payment methods align with general e-commerce trends in the DACH region. Invoice payment (Kauf auf Rechnung) remains highly popular in Germany, accounting for 30-40% of transactions. PayPal and credit card payments also represent substantial shares, at around 25-30% and 15-20% respectively. The adoption of new payment methods like mobile payment solutions is also observed, albeit at lower penetration rates.

Regulatory Framework and E-Rezept Impact in Germany

The regulatory environment significantly shapes the development of pharmacy e-commerce in the DACH region. Germany’s e-Rezept (electronic prescription) system stands as the most impactful recent regulatory development.

Germany’s E-Rezept Implementation: Following a phased rollout, the e-Rezept became mandatory for physicians in Germany as of January 1, 2024, for prescription of drugs covered by statutory health insurance (GKV). This mandate has accelerated patient and physician adoption. While initial redemption rates were modest, by Q1 2024, the weekly volume of e-Rezept redemptions via online pharmacies and corresponding apps surpassed 1.5 million. The Gematik, Germany’s national agency for digital medicine, reported over 100 million e-Rezept transactions by March 2024 since its inception.

The e-Rezept streamlines the prescription process and facilitates remote ordering and delivery of Rx medications, thus removing a significant barrier to online Rx sales. Projections indicate that by the end of 2025, a substantial portion of all prescriptions in Germany will be issued and redeemed digitally, with online pharmacies capturing a notable share of this digital redemption volume. The legal framework ensures the security and authenticity of e-prescriptions, utilizing the telematics infrastructure.

Austria and Switzerland Regulatory Context: In Austria, the “E-Rezept” has been in operation since 2020, facilitating digital prescription transfers between doctors and pharmacies. However, direct online dispatch of Rx medicines is generally restricted to specific cases or requires stringent verification processes. The primary online pharmacy market in Austria remains focused on OTC products.

In Switzerland, the sale of Rx medications online is tightly regulated by Swissmedic, with a strong emphasis on patient safety and professional oversight. Online pharmacies typically require a valid prescription from a Swiss doctor and often involve consultation with a pharmacist. The market for general e-commerce of pharmaceutical products is less developed for Rx items compared to Germany, focusing more on OTC and health-related non-medicinal products. The legal framework (Heilmittelgesetz) dictates strict requirements for online dispensing.

These distinct regulatory approaches directly influence the market structures and growth potential for Rx e-commerce in each DACH country, with Germany currently experiencing the most dynamic shifts due to the widespread implementation of the e-Rezept.

Frequently Asked Questions

What is the projected market volume for DACH online pharmacies in 2025? The DACH online pharmacy market is projected to reach approximately €6.5 billion by 2025, growing from an estimated €5.8 billion in 2024. This represents a compound annual growth rate (CAGR) of 11.9% from 2023 to 2025. Germany accounts for over 70% of this regional volume.

Which product categories are driving growth in DACH online pharmacy sales towards 2025? Over-the-Counter (OTC) medications and health & wellness products continue to form the largest segments, projected to grow 8-10% annually. The most significant shift is in Prescription (Rx) medications, particularly in Germany, where their share is expected to increase from 5-7% in 2023 to 12-15% by the end of 2025 due to e-Rezept adoption.

How is the e-Rezept influencing the German online pharmacy market for 2025? The mandatory e-Rezept in Germany, effective January 1, 2024, is a critical accelerator for online Rx sales. By Q1 2024, weekly e-Rezept redemptions via online channels surpassed 1.5 million, and over 100 million transactions were reported by March 2024. This is projected to significantly increase the share of Rx medications in the online market by 2025.

Who are the dominant players in the DACH online pharmacy market? Redcare Pharmacy N.V. (Shop Apotheke) holds the largest market share, estimated at 40-45% in Germany for OTC and health products. DocMorris (Zur Rose Group AG) is the second-largest, with an estimated 25-30% market share in the German online pharmacy segment. These top two players collectively account for over 65% of the total online sales volume in Germany.

For deeper strategic analysis, see our full report.

The DACH online pharmacy market is projected to reach €6.5 billion by 2025, demonstrating sustained growth across Germany, Austria, and Switzerland. This expansion is significantly driven by the increasing adoption of the e-Rezept in Germany, which is shifting the product category mix towards Rx medications, alongside the continued market leadership of concentrated players.